Biocryst Pharmaceuticals Inc (BCRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX)

BCRX 7.080

+0.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (37)	12/7/2006 1:19:59 PM
From: scaram(o)uche	of 269

Someone's whomping on it, probably the same someone who whomps on most of these cash-poor situations. But thanks for bringing it back into vision...... the cancer program is top-notch, and Roche is interested in the same target, molecule with different pharmacology. Lots of stuff new in the past year, with visible progress on the old stuff, including an I.M. formulation for seasonal flu. "Give me the shot, Doc. Thanks. What? In the butt? Damn. OK, go ahead. Much better than carrying Tammysflu around." That's all with the in depth due diligence of having throughly read the COMPANY'S LINE, mind you. :-) >> I gather Bioshield is in super slow mo mode << SARS is obviously not going to buy you a dime of MC. Ditto Ebola. West Nile, however..... that's good work to have percolating away. HCV investors bailing?? Seasonal flu is just getting established in the U.S., in the South. Sounds like peram stacks up well, given any spot light?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next